ArriVent BioPharma Reports First Quarter 2026 Financial Results
Go back to ArriVent BioPharma Reports First Quarter 2026 Financial Results| (NASDAQ: AVBP) | Delayed: 31.01 +0.40 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.61 | 52 Week High | $ | |||
| Open | $30.61 | 52 Week Low | $ | |||
| Day High | $31.51 | P/E | N/A | |||
| Day Low | $30.08 | EPS | $ | |||
| Volume | 181,581 | |||||

